Clinical Trials Directory

Trials / Completed

CompletedNCT03452670

Contemplative Well-being Apps for the Workplace

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The study will examine the use and impact of a meditation app delivered to adult workforce populations facing extreme time demands. Enrollees will be randomized to either app or a wait-list group, and will be assessed in terms of job and daily functioning, well-being, and biomarkers of immune function and stress physiology, and neural structure and function prior to randomization and again at multiple time points after participants commence app engagement. In order to assess efficacy, we will examine the longitudinal changes in all measures in both the mindfulness group, compared to wait-list control group.

Detailed description

Over the last 25 years, research on contemplative practices, a family of practices including mindfulness meditation and yoga, has advanced in domains both clinical and basic, motivated by burgeoning evidence of their efficacy for remediating psychopathology and augmenting well-being and resilience. However, much of this research has examined the effects of scheduled group interventions, delivered in-person by instructors over the course of several weeks. Far less research has looked at the delivery method that is most common and arguably most sustainable for busy adults, namely, smart phone delivered Contemplative Applications (apps) for Well-being (CWAs). The proposed study will examine the use and impact of an app delivered to populations facing extreme time demands.

Conditions

Interventions

TypeNameDescription
BEHAVIORALActive GroupParticipants will be provided with a contemplative well-being application (CWA) which will facilitate meditation for 10 minutes daily during the 8 week study period.
OTHERWaitlist GroupThe waitlist group will be maintained as a control group throughout all assessments and will be provided enrollment in CWA at the end of the 8 week study period.

Timeline

Start date
2016-06-06
Primary completion
2020-01-15
Completion
2020-03-11
First posted
2018-03-02
Last updated
2020-04-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03452670. Inclusion in this directory is not an endorsement.